Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uganda | 42 | 2024 | 1324 | 2.520 |
Why?
|
HIV Infections | 32 | 2024 | 17165 | 1.450 |
Why?
|
Carotid Artery Diseases | 5 | 2021 | 881 | 1.170 |
Why?
|
Rural Population | 11 | 2020 | 2268 | 0.830 |
Why?
|
HIV Seronegativity | 3 | 2021 | 208 | 0.810 |
Why?
|
Dyspepsia | 1 | 2022 | 118 | 0.780 |
Why?
|
Anti-HIV Agents | 7 | 2021 | 4491 | 0.770 |
Why?
|
Hypertension | 8 | 2022 | 8595 | 0.720 |
Why?
|
Fatty Acid-Binding Proteins | 2 | 2019 | 296 | 0.690 |
Why?
|
Esophageal Neoplasms | 3 | 2022 | 1648 | 0.680 |
Why?
|
HIV Long-Term Survivors | 1 | 2020 | 121 | 0.660 |
Why?
|
Helicobacter pylori | 1 | 2022 | 377 | 0.660 |
Why?
|
Helicobacter Infections | 1 | 2022 | 386 | 0.650 |
Why?
|
Biomass | 1 | 2019 | 134 | 0.630 |
Why?
|
Heating | 1 | 2019 | 101 | 0.630 |
Why?
|
Urban Health | 1 | 2021 | 533 | 0.630 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 282 | 0.600 |
Why?
|
Cooking | 1 | 2019 | 311 | 0.570 |
Why?
|
Anti-Retroviral Agents | 5 | 2019 | 1779 | 0.550 |
Why?
|
HIV Seropositivity | 1 | 2021 | 955 | 0.530 |
Why?
|
Preventive Health Services | 1 | 2020 | 570 | 0.490 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2016 | 418 | 0.480 |
Why?
|
Decision Support Techniques | 3 | 2018 | 2001 | 0.460 |
Why?
|
Interleukin-6 | 3 | 2019 | 3215 | 0.410 |
Why?
|
Cardiology Service, Hospital | 1 | 2014 | 242 | 0.410 |
Why?
|
Education, Medical, Continuing | 1 | 2017 | 830 | 0.400 |
Why?
|
Air Pollution, Indoor | 1 | 2019 | 893 | 0.390 |
Why?
|
C-Reactive Protein | 3 | 2019 | 3839 | 0.360 |
Why?
|
Deglutition Disorders | 1 | 2016 | 626 | 0.350 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1518 | 0.350 |
Why?
|
Heart Failure | 4 | 2022 | 11848 | 0.350 |
Why?
|
Risk Factors | 21 | 2022 | 74333 | 0.340 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 2825 | 0.340 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2061 | 0.340 |
Why?
|
Antigens, CD | 3 | 2018 | 4000 | 0.330 |
Why?
|
Hospitalization | 4 | 2018 | 10789 | 0.310 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2020 | 936 | 0.290 |
Why?
|
Blood Pressure | 3 | 2019 | 8525 | 0.270 |
Why?
|
Case-Control Studies | 7 | 2021 | 22052 | 0.260 |
Why?
|
Lower Extremity | 1 | 2014 | 1193 | 0.260 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 25941 | 0.260 |
Why?
|
Self Report | 2 | 2019 | 3711 | 0.260 |
Why?
|
Prevalence | 11 | 2022 | 15686 | 0.250 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5890 | 0.250 |
Why?
|
Echocardiography | 1 | 2017 | 4981 | 0.240 |
Why?
|
Feces | 2 | 2022 | 1455 | 0.240 |
Why?
|
Blood Pressure Determination | 2 | 2019 | 640 | 0.240 |
Why?
|
Medication Adherence | 1 | 2016 | 2165 | 0.240 |
Why?
|
Adult | 28 | 2022 | 220007 | 0.230 |
Why?
|
Kenya | 3 | 2021 | 749 | 0.220 |
Why?
|
Middle Aged | 29 | 2023 | 220359 | 0.220 |
Why?
|
Alcohol Drinking | 1 | 2016 | 4013 | 0.220 |
Why?
|
Male | 37 | 2024 | 359718 | 0.220 |
Why?
|
Quality of Life | 4 | 2024 | 13308 | 0.210 |
Why?
|
Peripheral Arterial Disease | 1 | 2014 | 1305 | 0.210 |
Why?
|
Inflammation | 2 | 2019 | 10755 | 0.210 |
Why?
|
Female | 38 | 2023 | 391246 | 0.210 |
Why?
|
Humans | 53 | 2024 | 760613 | 0.200 |
Why?
|
Africa South of the Sahara | 3 | 2020 | 742 | 0.200 |
Why?
|
Clinical Competence | 1 | 2017 | 4783 | 0.200 |
Why?
|
Loneliness | 1 | 2024 | 197 | 0.190 |
Why?
|
Lung Diseases, Obstructive | 1 | 2022 | 309 | 0.180 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2019 | 1894 | 0.180 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4024 | 0.180 |
Why?
|
Africa, Western | 1 | 2020 | 159 | 0.180 |
Why?
|
Smoking | 2 | 2022 | 9073 | 0.180 |
Why?
|
Rural Health | 2 | 2019 | 296 | 0.180 |
Why?
|
Cardiovascular Diseases | 4 | 2022 | 15760 | 0.180 |
Why?
|
Risk Assessment | 6 | 2021 | 24102 | 0.180 |
Why?
|
Eclampsia | 1 | 2020 | 56 | 0.180 |
Why?
|
Communicable Disease Control | 2 | 2023 | 844 | 0.170 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 89 | 0.170 |
Why?
|
Charcoal | 1 | 2019 | 64 | 0.170 |
Why?
|
Coal | 1 | 2019 | 119 | 0.160 |
Why?
|
Wood | 1 | 2019 | 91 | 0.160 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 1006 | 0.160 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15286 | 0.150 |
Why?
|
Maternal Mortality | 1 | 2020 | 300 | 0.150 |
Why?
|
Cohort Studies | 12 | 2022 | 41337 | 0.150 |
Why?
|
Nigeria | 1 | 2020 | 762 | 0.150 |
Why?
|
Stillbirth | 1 | 2020 | 367 | 0.140 |
Why?
|
Antigens, Bacterial | 1 | 2022 | 1155 | 0.140 |
Why?
|
Longitudinal Studies | 4 | 2022 | 14494 | 0.140 |
Why?
|
Fasting | 2 | 2020 | 1603 | 0.140 |
Why?
|
Glasgow Coma Scale | 1 | 2018 | 579 | 0.140 |
Why?
|
Aged | 16 | 2024 | 169143 | 0.130 |
Why?
|
Carbon Monoxide | 1 | 2019 | 541 | 0.130 |
Why?
|
Tanzania | 1 | 2020 | 1383 | 0.130 |
Why?
|
Developing Countries | 2 | 2019 | 2868 | 0.130 |
Why?
|
Acute Disease | 2 | 2018 | 7268 | 0.130 |
Why?
|
Prognosis | 4 | 2020 | 29661 | 0.120 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2020 | 518 | 0.120 |
Why?
|
Body Mass Index | 4 | 2022 | 12914 | 0.120 |
Why?
|
Prospective Studies | 5 | 2021 | 54306 | 0.110 |
Why?
|
Hematoma | 1 | 2018 | 769 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 748 | 0.110 |
Why?
|
Ankle Brachial Index | 1 | 2014 | 163 | 0.110 |
Why?
|
Patient Dropouts | 1 | 2016 | 412 | 0.110 |
Why?
|
Viral Load | 2 | 2020 | 3322 | 0.110 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.110 |
Why?
|
Atherosclerosis | 2 | 2022 | 3518 | 0.110 |
Why?
|
Life Expectancy | 1 | 2020 | 1247 | 0.110 |
Why?
|
International Cooperation | 1 | 2019 | 1433 | 0.100 |
Why?
|
Gastroenterology | 1 | 2019 | 571 | 0.100 |
Why?
|
Spirometry | 3 | 2022 | 924 | 0.100 |
Why?
|
Registries | 2 | 2018 | 8458 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.100 |
Why?
|
Aftercare | 1 | 2018 | 916 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20080 | 0.100 |
Why?
|
Forced Expiratory Volume | 3 | 2022 | 1809 | 0.100 |
Why?
|
Carotid Arteries | 3 | 2022 | 951 | 0.100 |
Why?
|
Lung | 2 | 2022 | 9994 | 0.100 |
Why?
|
Health Resources | 1 | 2017 | 935 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2128 | 0.090 |
Why?
|
Health Facilities | 1 | 2016 | 578 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1229 | 0.090 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 831 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2017 | 2362 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2420 | 0.090 |
Why?
|
Incidence | 3 | 2020 | 21391 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2016 | 867 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2022 | 14661 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2754 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2018 | 4353 | 0.080 |
Why?
|
Time Factors | 2 | 2021 | 40139 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1829 | 0.080 |
Why?
|
Health Policy | 1 | 2020 | 2677 | 0.070 |
Why?
|
Mass Screening | 2 | 2020 | 5422 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3725 | 0.070 |
Why?
|
Cerebral Hemorrhage | 1 | 2018 | 2660 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3310 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3898 | 0.070 |
Why?
|
Qualitative Research | 3 | 2022 | 2963 | 0.070 |
Why?
|
Body Weight | 1 | 2017 | 4611 | 0.070 |
Why?
|
Health Status | 1 | 2020 | 4082 | 0.070 |
Why?
|
Pandemics | 2 | 2023 | 8623 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2809 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2018 | 2064 | 0.070 |
Why?
|
Respiratory Function Tests | 2 | 2022 | 1683 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2019 | 3959 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12159 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7805 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2019 | 4412 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6379 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4647 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13505 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3386 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9716 | 0.060 |
Why?
|
Hospital Mortality | 2 | 2014 | 5418 | 0.050 |
Why?
|
Sexual Behavior | 2 | 2024 | 2086 | 0.050 |
Why?
|
Lipids | 1 | 2014 | 3336 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3226 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 2 | 2018 | 2569 | 0.050 |
Why?
|
HIV-1 | 1 | 2019 | 6849 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12628 | 0.050 |
Why?
|
Sex Factors | 3 | 2019 | 10546 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15840 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6659 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2592 | 0.040 |
Why?
|
Vital Capacity | 1 | 2022 | 965 | 0.040 |
Why?
|
Diastole | 1 | 2022 | 788 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9952 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4591 | 0.040 |
Why?
|
Logistic Models | 1 | 2014 | 13312 | 0.040 |
Why?
|
Public-Private Sector Partnerships | 1 | 2019 | 122 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 12289 | 0.040 |
Why?
|
Community-Institutional Relations | 1 | 2019 | 208 | 0.040 |
Why?
|
Limit of Detection | 1 | 2018 | 280 | 0.040 |
Why?
|
CpG Islands | 1 | 2022 | 1221 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2018 | 507 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11902 | 0.040 |
Why?
|
South Africa | 1 | 2022 | 1821 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2024 | 1273 | 0.030 |
Why?
|
Adolescent | 2 | 2022 | 87809 | 0.030 |
Why?
|
HIV | 1 | 2023 | 1579 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2018 | 554 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2016 | 123 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2019 | 580 | 0.030 |
Why?
|
Biostatistics | 1 | 2016 | 164 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2294 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 265 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2020 | 1817 | 0.030 |
Why?
|
Comorbidity | 2 | 2018 | 10553 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2020 | 1723 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3613 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2417 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2199 | 0.030 |
Why?
|
Respiratory Rate | 1 | 2014 | 175 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12531 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2476 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1500 | 0.020 |
Why?
|
Gestational Age | 1 | 2020 | 3564 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2493 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2931 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2907 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4286 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58980 | 0.020 |
Why?
|
United States | 1 | 2017 | 72448 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6359 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2501 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7233 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4372 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3598 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3562 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3928 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5508 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5961 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12810 | 0.020 |
Why?
|
Electrocardiography | 1 | 2019 | 6415 | 0.020 |
Why?
|
Young Adult | 2 | 2022 | 58748 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5397 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4180 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18413 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7344 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26179 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8045 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29746 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20509 | 0.010 |
Why?
|
Child | 1 | 2022 | 79799 | 0.010 |
Why?
|
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_